NHS England will be rolling out HPV self-testing kits to help more women take part in cervical screening 🗞️ cruk.ink/4hW2fTF
Christie Library & Knowledge Services
@christielibrary.bsky.social
Specialist NHS Library & Knowledge service for all staff and students based at The Christie NHS Foundation Trust. We also maintain the Christie Research Repository: https://christie.openrepository.com/ #christieresearchers
We are saddened to hear about the death of Dolly Parton. Dolly was an Honorary Fellow in recognition of her positive impact on children’s reading in the UK & globally, gifting millions of books to millions of children via her Imagination Library. Our thoughts are with her family.
👉 By E de Azambuja and N Harbeck, the ESMO Metastatic Breast Cancer Living Guideline provides immediate access to the June 2026 CPG recommendations, with notable systemic treatment updates in several subtypes, in an interactive, mobile-friendly format 🔗 https://ow.ly/8gl850ZEorF
EndoTheranostics: Soft robotics for cancer detection and treatment @ukri.org 👉🏽 youtu.be/3WVtWbITrhQ?...
EndoTheranostics: Soft robotics for cancer detection and treatment
YouTube video by UK Research and Innovation
youtu.be
Great news! New research we funded with Stand Up To Cancer could transform how people with rectal cancer are treated. Read more: cruk.ink/4xiRFLs #CancerResearchUKScience
Scientists have redefined how the key blood‑clotting protein fibrinogen behaves when it contacts air, overturning two decades of scientific consensus on wound healing. 📰 In The Journal of the American Chemical Society: doi.org/10.1021/jacs... 📰 In the Financial Times: www.ft.com/content/403a...
New BGS report: Optimising the impact of geriatricians Health and care systems across the UK are facing sustained workforce constraints at the same time as demand from an ageing population continues to rise. buff.ly/qtWzknL
New insights could help clinicians identify children with a type of muscle cancer who may develop aggressive disease, even without the usual marker. 🧬 Read about the hidden genetic drivers of this cancer 👇 https://www.sanger.ac.uk/news_item/hidden-drivers-of-aggressive-childhood-cancer-revealed/
Today, we honor health and humanitarian workers who care for communities affected by conflict and crisis, often at great personal risk. Health workers should not have to risk their lives to save lives. #WorldHumanitarianDay
A decade of evidence on the challenges of living with #lungcancer in Europe. All 11 Lung Cancer Europe Annual Reports now available together in a dedicated portfolio on our website. Covering diagnosis, treatment, clinical trials, QOL, mental health & more. lungcancereurope.eu/annual-reports #LCSM
APPLICATIONS CLOSING SOON! Don't miss your opportunity to apply for the new EACR-Worldwide Cancer Research Collaboration Fellowships. Application deadline: 03 September 2026 Find more information and submit your application here: eacr.org/collaboratio...
RCPsych response to Channel 4's documentary ‘The Great ADHD Myth?'. "The way we speak about neurodevelopmental conditions really matters. It can fuel harmful stigma experienced by people with the condition and risk discouraging them from seeking support and treatment." More ⬇️ shorturl.at/dFfVh
RCPsych statement on Channel 4 ADHD documentary
President Professor Subodh Dave comments on a new documentary about ADHD.
shorturl.at
“We’ve developed an approach with the Proton e-School which distils that knowledge into logical, manageable chunks.”🔬 Ed Smith, Clinical Director at The Christie, covers proton therapy and the thinking behind the Proton e-School in this episode of On Air, a pod about oncology. 🎧 bit.ly/45wuSiW
Episode 8 - Ed Smith
On Air · Episode
bit.ly
Guest Post — AI Can Find the Article. Can It Tell Which Version It Used? scholarlykitchen.sspnet.org/2026/08/19/g...
Guest Post — AI Can Find the Article. Can It Tell Which Version It Used? - The Scholarly Kitchen
In this AI era, establishing trust and validating article versions with persistent identifiers (PIDs) is more important than ever.
scholarlykitchen.sspnet.org
New data puts sun safety back in focus ☀️ Cancer Research UK says fewer than 4 in 10 adults in Great Britain have bought sunscreen so far this year. More than 20,000 people were diagnosed with melanoma in 2022. Read more 📰 bit.ly/sunscreen2026
Most people in Britain haven't bought sunscreen in 2026 - Cancer Research UK - Cancer News
Fewer than 4 in 10 adults have bought sunscreen so far this year, despite the high UV levels throughout the hot summer.
bit.ly
The ERC Work Programme 2027 has been adopted. Planning to apply for an ERC grant? The first call, Starting Grants, opens on 22 July. Find out more 👉 erc.europa.eu/news-events/...
New ERC Work Programme sets out 2027 funding opportunities
The European Commission has today adopted the European Research Council (ERC) Work Programme 2027, setting out the funding opportunities, grant budgets, competition timetable and application rules for...
erc.europa.eu
Congratulations Sacha Howell, Bruno Simões, @robclarkelab.bsky.social and the @preventbc.bsky.social Research Unit (PBC-RU) team for your nomination for a @fbmh-uom.bsky.social Hero Award for being at the forefront of breast cancer prevention & the Nature publication📰: www.nature.com/articles/s41...
THIS COULD TRANSFORM CANCER TREATMENT 👇 A little‑known group of hard-to-find immune cells could help transform cancer treatment, scientists at the University of Manchester’s Cancer Research UK Manchester Institute ( @cruk-mi.bsky.social) have found.
This summer has seen record-breaking temperatures and high UV levels – but according to data, more than 6 in 10 adults* in Great Britain haven't bought sunscreen this year. Find out why this matters: cruk.ink/4zhb9Br
A trial drug could help reduce side effects from blood cancer treatment. Researchers in Manchester are exploring whether the treatment can protect healthy blood cells, helping patients avoid infections, fatigue and delays to care. https://ow.ly/Cc9m50Zz1K0
Trial drug could reduce side-effects of blood cancer treatments - Manchester Cancer Research Centre
A UK-led clinical trial is set to test a new drug that could make cutting-edge cancer treatments safer and more accessible for thousands of patients with multiple myeloma, a type of blood cancer.
ow.ly
The NHS is inviting 500,000 men who have had or are living with prostate cancer to join Prostate Progress, a major research programme exploring earlier detection, treatment, side effects and quality of life. Read more 📰 bit.ly/4wsgXVT #prostatecancer #nhs #inthenews
Today in the Scholarly Kitchen, I have an interview with Natalie Ridgway at the Committee on Publication Ethics about their new Code of Conduct and Core Principles frameworks. Let's nerd out together! 😊 scholarlykitchen.sspnet.org/2026/08/10/n...
New Guidance from COPE: An Interview with Natalie Ridgway - The Scholarly Kitchen
An interview with Natalie Ridgway about new guidelines from the Committee on Publication Ethics
scholarlykitchen.sspnet.org
The Health Bill paves the way for a Single Patient Record. People support the potential benefits, but expect strong safeguards around privacy, security, transparency and accountability. Our latest explainer looks at what's proposed and the questions that remain. 👉 Read here: https://bit.ly/4hbDCCe
Scientists have identified two short windows after glioblastoma surgery when treatment could be delivered more effectively. The early-stage findings could help reshape care for one of the most aggressive forms of brain cancer. Read more in The Independent: https://ow.ly/W6hz50Zy0CE
Manchester researchers have developed a blood test to help doctors monitor advanced melanoma treatment in real time. By tracking circulating tumour DNA in the blood, the test could help identify whether treatment is working or needs to change weeks earlier than scans: https://ow.ly/TUvQ50ZwZz4
Guest Post - The Ghost in the Machine: Why Generative AI is a Crisis of Authorship, Not Just a Tool - The Scholarly Kitchen @scholarlykitchen.bsky.social 👉🏼 scholarlykitchen.sspnet.org/2026/01/22/g...
Guest Post - The Ghost in the Machine: Why Generative AI is a Crisis of Authorship, Not Just a Tool - The Scholarly Kitchen
Today's guest author raises the question of whether a researcher submitting an article that was significantly drafted by an LLM without clear disclosure is effectively engaging in a contemporary form ...
scholarlykitchen.sspnet.org
Looking to build your knowledge of the evolving immunotherapy landscape? Explore our upcoming study days on immune checkpoint inhibitors and bispecific antibodies, covering treatment approaches, toxicities and safe patient care. Learn more 🔗 bit.ly/4zeLF7V #cancereducation #immunotherapy
The Christie has treated the first patient in a pioneering trial investigating a TCR-NK cell therapy for advanced solid tumours. The early-stage study is exploring a new approach to cancer immunotherapy. Read more📰 bit.ly/4xp4UK9 1/2
First patient receives pioneering new cell therapy at The Christie
A woman who has spent more than 5 years living with advanced ovarian cancer has become the first patient in the world to receive a pioneering new cell therapy.
bit.ly
Study reveals why DNA damage from smoking and UV rays may cause cancer in some people but not others www.cam.ac.uk/research/new...
Study reveals why DNA damage from smoking and UV rays may cause cancer in some people but not others
Scientists have found the first direct evidence of the powerful role our genetic makeup plays in influencing our risk of cancer, with inherited genes interacting with acquired genetic mutations to sha...
cam.ac.uk